Aptevo Therapeutics Inc. — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2023-06-01

Reporting Person: Abdun-Nabi Daniel (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-01	Common Stock	M	297	—	Acquired	4768	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-01	Restricted Stock Unit	$	M	297	Disposed		Common Stock (297)	Direct
2023-06-02	Restricted Stock Unit	$	A	3571	Acquired		Common Stock (3571)	Direct

Footnotes

F1: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2: On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

F3: The RSUs vest in full on the first anniversary of the date of grant.